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Abstract
An ultimate goal of genetic research is to understand the connection between genotype and phenotype in order to
improve the diagnosis and treatment of diseases. The quantitative genetics field has developed a suite of statistical
methods to associate genetic loci with diseases and phenotypes, including quantitative trait loci (QTL) linkage mapping and
genome-wide association studies (GWAS). However, each of these approaches have technical and biological shortcomings.
For example, the amount of heritable variation explained by GWAS is often surprisingly small and the resolution of many
QTL linkage mapping studies is poor. The predictive power and interpretation of QTL and GWAS results are consequently
limited. In this study, we propose a complementary approach to quantitative genetics by interrogating the vast amount of
high-throughput genomic data in model organisms to functionally associate genes with phenotypes and diseases. Our
algorithm combines the genome-wide functional relationship network for the laboratory mouse and a state-of-the-art
machine learning method. We demonstrate the superior accuracy of this algorithm through predicting genes associated
with each of 1157 diverse phenotype ontology terms. Comparison between our prediction results and a meta-analysis of
quantitative genetic studies reveals both overlapping candidates and distinct, accurate predictions uniquely identified by
our approach. Focusing on bone mineral density (BMD), a phenotype related to osteoporotic fracture, we experimentally
validated two of our novel predictions (not observed in any previous GWAS/QTL studies) and found significant bone density
defects for both Timp2 and Abcg8 deficient mice. Our results suggest that the integration of functional genomics data into
networks, which itself is informative of protein function and interactions, can successfully be utilized as a complementary
approach to quantitative genetics to predict disease risks. All supplementary material is available at http://cbfg.jax.org/
phenotype.
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Introduction
Understanding the genetic bases of human disease has been an
overarching goal of biology since the foundation of genetics as a
scientific discipline. Efforts in quantitative genetics have utilized
new laboratory technology to quickly genotype and phenotype
large populations in order to determine which sequence features
are most related to specific phenotypes. There are currently two
major quantitative genetics approaches used to identify these
genotype-phenotype associations [1]. First, linkage mapping
examines genetically well-characterized populations, such as the
progeny of the crosses of reference strains or individuals related
through a known pedigree, to identify quantitative trait loci (QTL)
that contain causal mutations. Second, genome-wide association
studies (GWAS) can be performed on a more arbitrary population
to identify common genetic factors associated with a phenotype.
Hundreds of GWAS and QTL studies have been performed in
humans and in model organisms, resulting in the identification of
thousands of loci associated with phenotypes and diseases.
Despite promising results, each of these approaches for
quantitative genetics have common and unique unresolved issues
that limits their utility. Both QTL and GWAS approaches can
suffer from sampling biases. Population structure and proper
selection of representative case and control groups are challenges
for many GWAS, while linkage disequilibrium and limited genetic
diversity are challenges for many QTL studies [1–4]. Further,
many linkage mapping QTL studies lack the statistical power to
narrowly define a causal loci, often resulting in regions spanning
entire chromosomes that contain hundreds of candidate genes [5].
While these QTL regions are often broad, they can typically
explain a large fraction of phenotypic variation. In contrast,
GWAS typically define narrow regions of interest, but the amount
of heritable variation explained by these loci tends to be small,
possibly due to epistatic effects, rare alleles, or sampling biases [6].
For example, a meta-analysis GWAS of bone mineral density
(BMD) based on nearly 20,000 genotyped and phenotyped
individuals can only account for less than 3% of the observed
heritability of BMD [7].
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quantitative genetic techniques that are independent from the
biases inherent in linkage mapping QTLs and GWAS. Many of
the shortcomings of quantitative genetics could be attenuated by
considering the functional roles of proteins and by evaluating
existing large-scale experimental evidence. As such, we propose a
complementary, alternative approach to discovering gene-pheno-
type associations that applies machine learning techniques to
functional genomic measurements of the activities of genes and
proteins (e.g. expression, interactions, etc.) to identify candidate
genes that may be involved in a phenotypic outcome.
Recent efforts have undertaken the task of summarizing the
entirety of the experimental genomic literature into functional
networks of genes. These networks typically encode genes as
nodes, and contain experimental evidence of the relationships
between genes as edges between nodes. Computationally explor-
ing diverse functional genomics data through networks has been
intensively studied, with the purpose of elucidating the functional
roles of genes [8–11], predicting physical interactions [12,13], and
determining pathway structures [14]. Functional networks have
been produced in several organisms, including yeast [9,15], worm
[11,16], plant [17], mouse [10], and human [18]. These networks
have the advantage of being able to efficiently handle very-high
dimensional data and allow for visual analysis of results. However,
attempts to extract phenotypic information from these functional
networks are limited, with only the most naı ¨ve summarization of
links being applied in model organisms [11,17,19] as well as
human [20]. In order to utilize functional networks to identify
phenotypically important genes in higher organisms, where we
face complex biology and increased data heterogeneity, more
sophisticated computational approaches must be developed.
Historically, the fields of quantitative genetics and functional
genomics have been largely isolated from each other. A major
exception to this observation is the recent development of genetical
genomics and expression QTL studies [21,22]. These approaches
use the mapping populations of traditional quantitative genetics,
but utilize gene expression measurements as the phenotype to
map, rather than direct physiological or disease phenotypes. These
studies have begun to illuminate the regulatory programs of gene
networks and have quantified the effects of genetic diversity on
gene expression. However, these efforts suffer from the same
technical problems as other QTL studies, and the interpretation of
results is currently limited and is often disconnected from more
clinically relevant phenotypes and analyses [23].
We propose that functional genomics approaches can comple-
ment the potential shortcomings of quantitative genetics results in
two ways: first, by identifying candidates that may have been
missed due to biases in sampling or low allele frequency; and
second, by prioritizing candidates in loci containing many genes
due to limited mapping resolution. Here, we adopt a state-of-the-
art machine learning algorithm (support vector machine) to
analyze the functional network of the laboratory mouse to identify
genes involved in phenotypes and diseases. We show that our
approach significantly out-performs previous naı ¨ve functional
genomic methods used to predict phenotypes. Further, we
demonstrate that our results are complimentary to quantitative
genetics methods since a statistically significant number of our
predictions fall within QTLs or GWAS loci, but several of our
most confident predictions fall outside of these regions as well. We
have experimentally validated a phenotypic role for two genes
predicted to be involved in bone mineral density (BMD), a risk
factor for osteoporotic fracture, which were not identified by any
previous quantitative genetics study (Timp2 and Abcg8). Our results
concretely demonstrate that the combination of quantitative
genetics and functional genomics approaches can more compre-
hensively associate genes with phenotypes or diseases, which may
aid in identifying risk factors and potential drug targets.
Results/Discussion
In this study, we develop a new algorithm that accurately
predicts the phenotypic effects of genetic perturbations based on
functional genomic data, and we demonstrate that this approach
complements the results of quantitative genetics studies. In the
following sections, we first demonstrate that combining a genome-
wide functional relationship network with a state-of-the-art
machine learning algorithm can produce improved predictions
of genotype-phenotype relationships compared to previous naı ¨ve
algorithms. Second, we observe that both existing prior knowledge
and the biological nature of phenotypes affect the accuracy of our
approach. Third, we quantitatively show that our results
compensate for some of the shortcomings of prior GWAS and
QTL studies by providing complementary predictions based on
large-scale functional genomic data. Finally, we experimentally
demonstrate the power of this alternative approach by in vivo
validation of two of our unique predictions of genes involved in
bone physiology. The predictions made by our approach for all
examined phenotypes (as well as input data files, raw data outputs,
and source code) are available online at http://cbfg.jax.org/
phenotype.
Machine learning classification based on a functional
relationship network accurately predicts gene-
phenotype associations
Integrated functional relationship networks have the advantage
of summarizing multiple complex datasets into a concise, visually
interpretable graph representation where genes are nodes and
connections between them represent the probability that two genes
work together [8–11,15,17–19]. We applied a Bayesian network
approach for supervised data integration, which assesses the
Author Summary
Many recent efforts to understand the genetic origins of
complex diseases utilize statistical approaches to analyze
phenotypic traits measured in genetically well-character-
ized populations. While these quantitative genetics meth-
ods are powerful, their success is limited by sampling
biases and other confounding factors, and the biological
interpretation of results can be challenging since these
methods are not based on any functional information for
candidate loci. On the other hand, the functional genomics
field has greatly expanded in past years, both in terms of
experimental approaches and analytical algorithms. How-
ever, functional approaches have been applied to under-
standing phenotypes in only the most basic ways. In this
study, we demonstrate that functional genomics can
complement traditional quantitative genetics by analyti-
cally extracting protein function information from large
collections of high throughput data, which can then be
used to predict genotype-phenotype associations. We
applied our prediction methodology to the laboratory
mouse, and we experimentally confirmed a role in
osteoporosis for two of our predictions that were not
candidates from any previous quantitative genetics study.
The ability of our approach to produce accurate and
unique predictions implies that functional genomics can
complement quantitative genetics and can help address
previous limitations in identifying disease genes.
Using Functional Genomics to Find Disease Genes
PLoS Computational Biology | www.ploscompbiol.org 2 November 2010 | Volume 6 | Issue 11 | e1000991conditional probability that individual data sources contain
evidence for gene relationships based on a training set of positive
examples (e.g. gene pairs known to interact) and negative examples
(e.g. gene pairs not known to interact). Given these learned
conditional probabilities for each data source and prior probabil-
ities for gene relationships, Bayesian inference is used to generate a
network defined by pair-wise posterior probabilities of functional
relationships between all genes. In order to use this network to
predict genotype-phenotype associations, we must exclude pheno-
typic data to avoid circularity. Therefore we gathered diverse
genomic data for inputs, including protein-protein physical
interactions [24–27], phylogenetic profiles [28,29], homologous
functional relationship predictions in yeast [9], and expression and
tissue localization data [30–32] to construct a functional
relationship network for the laboratory mouse (Figure 1; input
data sources and integration methods are available in Supple-
mental Text S1). We integrated these diverse data using a
Bayesian network trained using a gold standard derived from the
Mouse Genome Informatics (MGI) [33] annotations to the Gene
Ontology (GO) [34] biological process branch as described
previously [10] and in Supplemental Text S1. This procedure
resulted in a probabilistic functional relationship network for the
laboratory mouse that combines diverse knowledge and data.
Given this integrated functional relationship network, we
applied two methodologies to generate hypotheses about geno-
type-phenotype associations. Each method is supervised, and thus
requires a starting set of genes known to be associated with each
phenotype or disease of interest. Here, we used the mammalian
phenotype (MP) ontology [35] annotations to create our training
sets of gene-phenotype associations. For each phenotype exam-
ined, genes were considered positive examples if any allele is
annotated to the phenotype and all other genes were considered
negative examples.
First, our new approach treats the connection weights from the
integrated network (i.e. the inferred probabilities that genes are
functionally related) as features for support vector machine (SVM)
classification [36]. In order to reduce the size of the feature space,
only connection weights to known genes associated with a
phenotype (i.e. positive examples) are used for training. We then
apply the trained SVM to classify all genes for each phenotype
(Figure 1). For ease of interpretation, the raw SVM scores were
normalized to represent probabilities of gene-phenotype associa-
tion as described in the Methods section. The result of this
approach is used in all of our later analyses, and is denoted simply
as ‘‘SVM’’ below.
Second, in order to establish a baseline for comparison, we also
explored a naı ¨ve method previously used in other model
organisms [11,17,19], as well as human [20], which assigns a
score to an unknown gene by its summed connection weights to
all known genes associated with a phenotype in the integrated
network. For this method, genes were ranked according to their
summed connection weight, which we denote as ‘‘summed
weight’’ throughout the text. (In addition to these two
approaches, we also trained SVMs directly on the input data
Figure 1. Schematic of our SVM-based functional genomics approach to phenotype prediction. As shown in the upper half, a functional
relationship network was first constructed for the laboratory mouse based on integration of diverse data types, excluding phenotype and disease
data to avoid contamination in evaluation. These data were integrated together using Gene Ontology annotations as a gold standard using an
established Bayesian pipeline [10]. The resulting network consists of genes as nodes and connections between them representing the probability of
two genes participating in the same biological process. This network was used as the basis for an SVM classifier to predict genes associated with
phenotypes. As shown in the lower half, annotations to the mammalian phenotype (MP) ontology were used to create gold standards (i.e. training
sets) for each SVM. Annotations were propagated along the ontology tree to produce positive training examples (genes associated with the
phenotype, labeled P and shown in red). All other genes were considered as unknowns (labeled U and shown in grey). SVMs were provided with
input features consisting of network connection weights to positive genes for each phenotype and each SVM was trained to classify unknown
examples in this phenotype-specific feature space.
doi:10.1371/journal.pcbi.1000991.g001
Using Functional Genomics to Find Disease Genes
PLoS Computational Biology | www.ploscompbiol.org 3 November 2010 | Volume 6 | Issue 11 | e1000991used to create the functional relationship network. As detailed in
Supplemental Text S2, this approach induced a dramatic
increase in feature space and running time, and was always
outperformed by our method.)
Each of these approaches was applied to a set of 1157 diverse
phenotypes defined by the mammalian phenotype (MP) ontology
[35]. Predictions were computationally evaluated through boot-
strapping for each method and phenotype. Performance
summary statistics were calculated, including the area under
the precision-recall curve (AUPRC) and precision at n% recall.
To establish general performance measures, we first focused on
30 MP terms from the first level of the ontology, which represent
a wide sampling of ‘‘high-level,’’ well-characterized phenotypic
areas [37]. Cross-validation performance for these 30 high-level
terms revealed significant improvement in performance for our
new SVM-based approach compared to the summed weight
m e t h o d( F i g u r e2 ) .T h em e d i a nA U P R Cf o rt h e s et e r m su s i n g
SVM is roughly 1.8 fold greater than for the summed weight
approach (results for a sampling of three representative MP terms
are shown Figure 2B; full results for all 30 phenotypes are
available in Supplemental Figure S1). This performance
improvement is especially apparent for our most confident
predictions (i.e. at the low-recall, high-precision end), which is
most important for subsequent biological validation where only a
handful of candidates can be reasonably examined. At 1% recall
(roughly 200 predictions), our SVM approach achieved a median
of 75% precision, compared to 43% for the summed weight
method; and at 10% recall (roughly 2000 predictions) our SVM
approach outperforms summed weight by 40% to 15%. The
comparisons of precisions at multiple levels of recall confirm the
overall improved quality of our algorithm over naı ¨ve methods
(Figure 2C).
SVM-based phenotype predictions are most accurate for
large phenotype terms
Prediction algorithms often show drastic differences in baseline
performance related to the number of training examples (i.e. the
number of genes annotated to each MP term) [38], which is an
important factor in fully evaluating the strength of algorithms. We
therefore assembled all phenotype terms into groups of 30–50, 50–
100, 100–200, and 200–300 annotated genes to assess the impact
of term size on results. Both the summed weight and the SVM
method achieved better performance than random, regardless of
term size (Figure 3A). However, our SVM-based method
demonstrated a more significant improvement for reasonably
large terms (with more than 100 genes annotated, or .0.5% of the
genome; shown in Figure 3B). For example, in the 200–300
annotation group, our SVM approach achieved an average
improvement of 1.78 fold over summed weight, and in the 100–
200 annotation group we observed a 1.67 fold improvement. The
superior performance of our SVM-based method implies that
more sophisticated machine learning techniques are better able to
fully extract phenotypic information from functional networks
than previous simpler approaches.
Phenotype prediction is particularly accurate for
biologically specific phenotypes
As discussed above, there is a significant effect on prediction
accuracy based on the number of known gene annotations to each
phenotype. In addition to this size effect, there appears to be a
strong correlation between prediction accuracy and the ability of a
phenotype to be accurately and reproducibly measured. For
example, among the phenotypes most accurately predicted by our
approach are ‘‘decreased IgE level’’ (MP:0002492) and ‘‘decreased
circulating free fatty acid level’’ (MP:0002702). Each of these is a
Figure 2. Significantly improved performance of our network-based SVM method for predicting well-defined phenotypes. Thirty
well defined, high level MP terms were obtained from MGI [37], which represent a wide sampling of phenotypes. A. Precision at 10% recall is shown
for these 30 MP terms using our method (SVM; y-axis) and the summed weight method (x-axis). B. Precision-recall curves for an indicative selection of
three high level phenotypes for our SVM-based method and the summed weight method. Full results for all examined phenotypes are available at
the supplementary website (http://cbfg.jax.org/phenotype) and in Supplemental Figure S1. C. Box and whisker plots comparing our SVM approach to
summed weight using several different summary statistics, including AUPRC (area under the precision recall curve), precision at 1%, 10%, 20% and
50% recall, each expressed as fold change over random precision. In all cases our approach outperforms the summed weight method.
doi:10.1371/journal.pcbi.1000991.g002
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such as ‘‘concentration’’ or ‘‘width’’. In contrast, among the most
poorly predicted phenotypes are ‘‘head bobbing’’ (MP:0001410),
‘‘disheveled coat’’ (MP:0001511), and ‘‘lethargy’’ (MP:0005202),
which are more qualitative in nature (i.e. presence/absence calls)
or which are measured based on a subjective ‘‘severity score’’.
While it is difficult to concretely assess the notion of ‘‘phenotypic
specificity,’’ we generally observe in our overall results that more
concrete phenotypes tend to perform more accurately. In order to
quantify this effect, we conducted a small, blinded survey of 19
laboratory biologists. Survey respondents ranked phenotypes on a
scale from 1 (not specific, qualitative) to 5 (highly specific,
quantitative). Based on these results, we found a small, but
significant, difference between the top and bottom 20 phenotypes
ranked by overall precision (3.6 versus 3.3; p=0.008; full survey
results in online supplement), which confirms our observation that
more quantitative phenotypes tend to perform better. This
phenomenon is not surprising in that functional genomic evidence
is more likely to be informative for well-defined phenotypes.
However, this effect is also promising in that better defined
phenotypes are more likely to reflect specific molecular-level
changes that may be more relevant from a drug target or clinical
diagnosis perspective.
Network-based SVM predictions complement
quantitative genetics in identifying disease genes
Our prediction approach is based on an integrated functional
relationship network, rather than pure genotype and phenotype
information, and thus potentially avoids several of the caveats of
quantitative genetics methods. While we expect that our approach
and GWAS/QTL studies will share many candidates, since the
underlying assumptions of functional genomics and quantitative
genetics are very different, we also expect to obtain predictions
unique to each method. We evaluated the utility of our functional
genomic approach both by comparing our predictions to previous
quantitative genetics loci, and by experimentally validating
predictions unique to our approach.
We selected bone mineral density (BMD) as an example to
evaluate our approach since this is an extensively studied heritable
trait in both human populations and mammalian model organisms
[5]. We compared the predictions for the phenotype ‘‘abnormal
bone mineralization’’ (MP:0002896) from our functional genomic
approach against a comprehensive list of mouse linkage QTLs and
human GWAS results examining BMD [5]. Due to the limited
resolution of some mouse QTL studies, fully 83% of mouse genes
lie under the confidence interval of at least one BMD QTL
reported in the literature (Figure 4). Despite this lack of specificity,
we still observe a significant overlap between our top predictions
and these QTLs as 93 of our top 100 predictions are contained
within a QTL confidence region (hypergeometric p-value=0.002).
Similarly, genomic regions within 5cM of a QTL peak contain
16% of mouse genes, but contain 71 of our top 100 predictions
(hypergeometric p-value=7610
232).
While this overlap is significant, a large number of our most
confident predictions (,30% of the top 100) do not fall within
5cM of a QTL peak and are thus not likely candidates from
previous studies. We consider these to be candidates likely missed
by prior quantitative genetics studies due to sampling, population
biases, epistasis, or other circumstances. In fact, two of our most
confident predictions for genes associated with BMD are not
candidates from previous quantitative genetics studies, but both
have been experimentally verified as described below.
In vivo testing validates a role for Timp2 and Abcg8 in
mammalian bone density
For experimental validation, we selected two of our genes
predicted for association with BMD that are not candidates from
any previously reported linkage QTL or GWAS regions [5]: Timp2
and Abcg8. These genes are our two most confident predictions for
involvement in BMD that are not quantitative genetics candidates
and that have existing, live knockout strains available for testing
(see Supplemental Table S3 for all top BMD predictions). In the
laboratory mouse, the Timp2 gene falls on the distal end of
chromosome (Chr) 11, outside of all previous QTLs identified on
Figure 3. Network-based SVM approach performs best for reasonably large terms. A. Phenotypes were grouped by the number of genes
annotated to each MP term (200,300, 100,200, 50,100 and 30,50, respectively). The performance of summed weight (dark blue), and our
network-based SVM approach (red) are compared against random (cyan) using box-and-whisker plots of precision at 1% recall. B. Fold improvement
of summary statistics over random for our network-based SVM approach (red) and the summed weight method (dark blue) for reasonably large terms
(.1.5% of the genome annotated, i.e. 200–300 genes).
doi:10.1371/journal.pcbi.1000991.g003
Using Functional Genomics to Find Disease Genes
PLoS Computational Biology | www.ploscompbiol.org 5 November 2010 | Volume 6 | Issue 11 | e1000991Chr 11. The Abcg8 gene lies on the distal end of Chr 17. One
previous QTL study found a BMD QTL on Chr 17 that contains
over 100 genes, including Abcg8 [39]. However, Abcg8 was not
considered as a possible candidate gene in this study because there
is no known polymorphism within 20 kb of Abcg8 in the two strains
crossed for linkage mapping (NZB/B1NJ and RF/J). None of the
20 BMD loci identified in human GWAS lie near either Timp2 or
Abcg8 (Figure 4).
We have high confidence in the accuracy of these candidates for
two reasons. First, our approach produced accurate cross-
validation results for many osteoporosis and BMD related
phenotypes such as ‘‘abnormal bone density’’ (MP:0005007) and
‘‘abnormal bone structure’’ (MP:0003795) (Figure 5A–B). Second,
in our functional network, Timp2 and Abcg8 are linked to several
genes known to be related to BMD and bone diseases in the
Online Mendelian Inheritance in Man (OMIM) database
(Figure 5C and Supplemental Tables S1 and S2). For example,
Timp2 is directly linked to Mmp2, which is a known player in
hereditary osteolysis (OMIM # 259600). It is also linked to the
metalloproteinases Mmp8 and Mmp14, the collagen Col1a1, and the
glycoprotein Sparc, all of which have been associated with bone
defects in the literature [40,41]. Among the top interactors of
Abcg8 are the collagens Col1a2 and Col1a1, which are involved in
osteoporosis (OMIM #166710). Additional interactors of Abcg8
include the bone related genes Sparc and the proteoglycan Bgn. All
of these connections are supported by multiple evidence sources,
including expression, physical interactions and phylogenetic
profiles (Supplemental Table S1).
Despite the connections apparent in our functional network, to
our knowledge no bone related phenotypes have been reported for
either Timp2 or Abcg8 knockout mouse strains. However, there is
limited evidence in the literature that these genes may play a role
in bone biology. Polymorphisms in the human Timp2 gene were
found to be weakly associated with increased risk of non-vertebral
osteoporotic fracture in a small study of post-menopausal women
[42]. Abcg8 is involved in cholesterol absorption and serum
cholesterol levels [43], which are processes that have been related
to bone homeostasis through other genes [44,45]. These two cases
show that our integrative approach is able to draw implicit
information from a variety of high throughput data to confidently
associate these two proteins with BMD defects.
We examined femoral volumetric BMD (vBMD) in male Timp2
and Abcg8 knockout mice at 16 weeks of age. Animals homozygous
for deletion were compared to heterozygous littermate controls. As
shown in Figure 6A, we observed a significant decrease of roughly
8% of vBMD in Timp2
2/2 male mice (p-value=0.033) and a
significant increase of roughly 6.5% was observed in Abcg8
2/2
male mice (p-value=0.044). Most individual mouse QTLs account
for a 3–6% change in vBMD [5], which places our observed
differences in the high end of this range. We also examined
phenotype results from the Deltagen and Lexicon collections of
over 200 knockout mouse strains (http://www.informatics.jax.
org/external/ko/) to assess the likelihood of identifying genes with
a significant affect on BMD. While these strains were not
randomly selected, we can use these results to gain an estimate
of how often single gene deletions affect bone density. Of 206
strains tested, only 20 exhibited a significant alteration in BMD,
indicating a roughly 10% background rate. Thus, our confirma-
tion of 2 out of 2 predictions is well above the expected result by
chance.
Furthermore, we observed morphological defects in the bones of
both strains, including an increase in periosteal circumference in
the Timp2
2/2 mice (p-value=0.0105) and an increase in cortical
thickness in the Abcg8
2/2 mice (p-value=0.032) as shown in
Figure 4. Two of our accurate predictions were not implicated by previous quantitative genetics studies. A chromosomal map of the
laboratory mouse genome is shown, labeled with results compiled from previous human GWAS (red triangles) and mouse QTL studies (blue lines) of
bone mineral density (BMD) [5]. Due to the limited resolution of some QTL studies, 83% of the mouse genome lies underneath the 95% confidence
interval of at least one QTL. We experimentally confirmed two of our most confident predictions for bone defects that were not implicated in any
previous QTL or GWAS effort: Timp2 and Abcg8 (green arrows). While Abcg8 falls underneath a single QTL on chromosome 17, it was not a candidate
gene for the loci as there are no polymorphisms within 20kb of Abcg8 in the strains crossed for this study [39]. Timp2 does not lie under any
previously implicated loci.
doi:10.1371/journal.pcbi.1000991.g004
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bone mass, but morphologic factors such as bone shape also
contribute to fracture risk [46]. The decrease in bone density seen
in Timp2
2/2 and the increase density seen in Abcg8
2/2, along with
the noted differences in bone morphology, indicate that these
genes are likely related to osteoporotic fractures. Neither of these
genes is a candidate from any previous quantitative genetics study
of BMD, which indicates that our approach produces results that
are complementary to GWAS and QTL studies.
Conclusions
We have developed a novel SVM-based classification method to
predict genotype-phenotype associations based on a probabilistic
functional relationship network integrated from diverse data
sources. Through bootstrapping and cross validation we confirmed
its superior performance compared to previous approaches. Using
osteoporosis related phenotypes as an example, we have
computationally demonstrated and experimentally validated how
integration of functional genomics data can facilitate disease gene
identification in a complementary manner to quantitative genetics
approaches.
This study demonstrates the potential for integrative functional
relationship networks to be applied in new ways, especially when
successfully combined with sophisticated machine learning
techniques. Functional networks have been intensively studied
during recent years, resulting in multiple networks available for
several model organisms [8–11,15–19] as well as for humans
[18,20]. In addition to the original applications of these networks,
our results demonstrate that functional relationship networks can
be used to accurately predict gene-phenotype associations, and
that supervised machine learning approaches outperform the
simple fusion methods previously applied to this problem
[11,17,19,20]. By combining two computational learning meth-
odologies (Bayesian network integration of diverse data into a
probabilistic relationship network and SVM classification), we
were able to utilize the complementary advantages of each method
to produce accurate results. We anticipate that such an approach
could be a prototype for other forms of network-assisted prediction
methods in cases where gold standard positive and negative
examples are available for training.
We have also shown that our integration of functional genomics
data is able to identify potential disease genes not yet identified by
any quantitative genetics screens. The caveats of quantitative
genetics, including sampling biases, rare allele effects, epistasis, and
potentially limited explanatory power have been recognized for
years [1–4]. Our approach suggests a complementary new avenue
Figure 5. Predicting novel candidates associated with bone phenotypes. Precision-recall curves of the cross-validation results for A.
‘‘abnormal bone density’’ (MP:0005007) and B. ‘‘abnormal bone structure’’ (MP:0003795). For both phenotypes, our network-based SVM achieved a
better performance than summed weight. C. A network view of functional relationships centered around Timp2 and Abcg8. Nodes indicate genes,
and the thickness of lines indicates relationship confidence. Both Timp2 and Abcg8 are connected to several genes that demonstrate a bone
mineralization phenotype or are otherwise implicated in osteoporosis. Networks were visualized using VisANT [50].
doi:10.1371/journal.pcbi.1000991.g005
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genomics data in model organisms, which is generally not included
in quantitative genetics studies. We expect that a combination of
complementary approaches will be required to realize the ultimate
goals of improved genetic diagnosis, treatment, and prevention
that form the basis of personalized medicine.
Methods
Constructing the functional relationship network
To avoid circularity in the phenotype prediction process, we
created a functional relationship network that excludes phenotypic
data. We pre-computed this network following the Bayesian
method described in [10] by integrating diverse sources of
genome-scale data. This results in a network with genes as nodes
and links between them representing the probability that the pair
participates in the same biological processes. The input data used
to generate this network is listed in Supplemental Text S1 and
the complete network is downloadable at http://cbfg.jax.org/
phenotype.
Gold standards for phenotype predictions
We utilized the annotations to the mammalian phenotype (MP)
ontology [35] as the gold standard gene sets. The MP ontology is
organized into a multi-level hierarchy, with broader terms
describing more general phenotypes at the top and more specific
terms describing detailed phenotypes toward the bottom. Within
this hierarchy, any annotation to a child node implies annotation
to all of its parent nodes. Therefore, for each MP term, positive
examples were taken as the genes annotated directly to this term or
to any descendent of this term. Negative examples were assumed
to be all other genes.
We obtained the phenotype annotations for mouse from MGI
[33] in Jan 2009. These included 134722 entries, containing alleles
for 11382 genes in total (,55% of the mouse proteome). If any
allele of a gene was annotated to a phenotype, we associated that
gene with the phenotype. For each term, the number of positive
examples np, corresponds to all genes known to be associated with
the phenotype or its descendents in the MP hierarchy. All other
genes were considered as negative examples; the total number of
negative examples is denoted as nn.
Phenotype prediction by summed weight
A summed weight approach has been applied in previous
studies [11,17,19,20] to predict phenotypes of uncharacterized
mutants in other model organisms. Variants of this approach have
been used for function prediction and other forms of analysis [18].
For each phenotype, a score, f, is calculated for each gene, x, as the
sum of all links between the gene and all positive examples from
the gold standard:
f(x)~
X np
i~1
(K(xi,x)),
where K(xi,x )represents the connection weight between the genes
xi and x in the probabilistic functional network.
Phenotype prediction using positive examples as
features in a SVM
Predicting phenotypic effects by summing connection weights
to positive examples has achieved satisfactory performance
[11,17,19,20]. Although straightforward, this approach does not fully
explore the predictive potential of functional networks that can be
achieved by applying more principled machine learning techniques.
We therefore designed a new method combining Support Vector
Machine (SVM) classifiers with a functional relationship network to
predict phenotypes associated with each mouse gene.
For each phenotype, we constructed a specific feature space
consisting of the network connection weights to all positive
examples of the phenotype. Therefore the number of features
varies across different phenotypes and is equal to np, the number of
genes positively associated with that phenotype. These features
were used as input vectors for a set of linear SVMs [36]:
Minimize :
1
2
DD~ w wDD
2zj
X
p:yi~1
jpz
X
n:yj~{1
jn
Figure 6. Bone phenotype assessment for Timp2 and Abcg8
deficient mice. A. Total femoral volumetric bone mineral density
(vBMD) is significantly lower in Timp2 deficient male mice (N=5) as
compared to haploinsufficent littermate controls (N=7, p=0.033). In
contrast, a significant increase in vBMD was observed in Abcg8 deficient
male mice (N=7) as compared to haploinsufficent littermate controls
(N=9,p=0.044). Error bars represent standard error. In addition to BMD
effects, morphological defects were observed in both strains. B. Abcg8
deficient male mice show an increase in cortical thickness compared to
controls (p=0.032). C. Timp2 deficient male mice exhibit increased
periosteal circumference compared to controls (p=0.0105).
doi:10.1371/journal.pcbi.1000991.g006
Using Functional Genomics to Find Disease Genes
PLoS Computational Biology | www.ploscompbiol.org 8 November 2010 | Volume 6 | Issue 11 | e1000991Subject to : Vk : yk½~ w w:~ x xkzb §1{jk
where xi is the feature vector for gene i (i.e. the connection weight
to the positive examples), yi equals to 1 or 21 depending on
whether gene i is annotated to the phenotype term or not, p is any
gene annotated to the term in study, and n is any of the other
genes.
Alternately, we could use the connection weight to all examples
as the input vectors, regardless of whether they are positive or
negative examples. However, this construction is excessively time-
consuming for SVM calculations. For example, in a Lagrangian
SVM, the running time is approximately O(nN
2), where n is the
number of examples and N is the number of features. In
comparison, our approach takes only an average of 6 minutes
(approximately 100 fold reduction in time) for a 25-round
bootstrap validation to generate the prediction results for each
phenotype term. Another intuitive algorithm is to directly input all
original data into a linear SVM [38]. However, this approach is
both time consuming due to the large number of features involved
and performed less accurately than our approach (see Supple-
mentary Text S2).
Predicting phenotypes and evaluating predictive
performance by bootstrapping
In order to limit over-fitting, and because each phenotype is
only associated with a limited set of genes, we consider bootstrap
cross-validation to be an ideal method for estimating error rates
[47]. We therefore applied bootstrap aggregation to predict genes
associated with each phenotype and to estimate accuracy.
Intuitively, this method trains models on a subset of genes and
tests it on a different subset of genes repeatedly, thus minimizing
the possibility of over-fitting and the effects of potentially mis-
annotated genes. Specifically, for each iteration, genes were
sampled with replacement to form a training set, and all the
remaining genes form a test set. Classification values were only
recorded for the test set during each iteration. The final outputs
were calculated as the median of the out-of-bag values across 25
independent bootstraps, and the precision-recall curves were
derived from these median values.
Probability estimation
The outputs from the SVMs represent the distances from the
examples to the separating hyperplane [36], which are not
intuitive to understand. To make the value of these outputs more
comprehensible, we estimated the probability of being annotated
to a phenotype by fitting the output distribution of positive and
negative examples with two normal distributions. According to
Bayes’ rule,
p(yDX)~
p(XDy)p(y)
p(X)
~
p(XDy)p(y)
p(XDy)p(y)zp(XDn)p(n)
where
p(XDy)~
1
ﬃﬃﬃﬃﬃﬃ
2p
p
sy
e
{
(x{my)
2
2sy
2
and p(XDn)~
1
ﬃﬃﬃﬃﬃﬃ
2p
p
sn
e
{
(x{mn)
2
2sn
2 ,
where X is the raw output value for a gene, y represents positive
examples, n represents negative examples, sy and sn are the
standard deviations of the raw outputs for positive and negative
examples, and my and mn are the mean of the raw outputs for
positive and negative examples. Based on these distributions we
estimate the probability of a gene being associated with a
phenotype as p(y|X), given its observed value X. Outputs with a
value lower than the average of negative examples are assigned as
zero. Transforming to probability does not affect the ordering of
results, and consequently has no effect on our performance
evaluation metrics. We provide the complete list of predictions in
terms of probability on our supporting website http://cbfg.jax.
org/phenotype.
Performance evaluation
To assess the performance of the phenotype predictions, we
obtained precision-recall curves and summary statistics for each
phenotype. We computed the precision at various recall rates as
previously described [48]. Precision is defined as the number of
genes correctly classified as having a certain phenotype (true
positives, TP) divided by the total number of genes classified as
having that phenotype (TP and false positives, FP):
TP
TPzFP
Recall is defined as the percentage of genes annotated to a given
phenotype that were classified as having that phenotype:
TP
TPzFN
where FN represents the number of false negative predictions.
There is a trade off between precision and recall in that the most
confident predictions are more likely to be accurate, whereas in
order to achieve high levels of recall, we must accept a lower level
of precision. As such, precision values are measured at many levels
of recall to produce a curve. In order to produce single number
summary statistics from these curves, we use the area under the
precision-recall curve (AUPRC) as well as the precision at fixed
levels of recall, including 1%, 10%, 20% and 50%.
Ethics statement and animal husbandry
All studies and procedures were approved by the Institutional
ACUC of The Jackson Laboratory. The B6.129S4-Timp2
tm1Pds/J
(Stock Number 0008120) and B6.129-Abcg8
tm1Elk/J (Stock
Number 008763) mice were originally purchased from the
resource colonies of The Jackson Laboratory (Bar Harbor, ME)
and colonies were maintained by pair mating heterozygous mice.
After weaning, mice were maintained in groups of 3–5 in
polycarbonate boxes (130 cm
2) on bedding of sterilized white
pine shavings under conditions of 12 hours light; 12 hours
darkness. All mice used in this study had free access to water
and diet for the duration of the study.
Peripheral quantitative computed tomography
assessment of volumetric BMD
Total femoral volumetric BMD (vBMD) and femoral geometry
was assessed ex vivo by peripheral quantitative computed
tomography (pQCT). Specifically, mice were killed at 16 weeks
of age and femurs were isolated and fixed in 95% ethanol for 14
days. Femurs were measured for density using an SA Plus pQCT
densitometer (Orthometrics, Stratec SA Plus Research Unit,
White Plains, NY) as previously described [49]. Daily quality
control of the SA Plus instrument’s operation was checked with a
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with threshold settings to separate bone from soft tissue and to
separate cortical from sub-cortical bone. Precision of the SA Plus
for repeated measurements of a single femur was previously found
to be 1.2–1.4%. Isolated femurs were scanned at 7 locations at
2 mm intervals, beginning 0.8 mm from the distal ends of the
epiphyseal condyles. Total vBMD values were calculated by
dividing the total mineral content by the total bone volume and
expressed as mg/mm
3. Periosteal circumference and cortical
thickness measures were made at the exact midshaft of the femur.
Supporting Information
Figure S1 Well defined, high level MP terms were obtained
from MGI, which represent a wild sampling of phenotypes.
Precisions at different levels of recall were calculated for both the
summed weight method (left) and the network-based SVM method
(right), where the latter shows significant improvement.
Found at: doi:10.1371/journal.pcbi.1000991.s001 (1.35 MB TIF)
Table S1 Supporting evidence for top connectors to the
candidate genes.
Found at: doi:10.1371/journal.pcbi.1000991.s002 (0.06 MB
DOC)
Table S2 Interaction weights (posteriors) of local networks
surrounding Timp2 and Abcg8.
Found at: doi:10.1371/journal.pcbi.1000991.s003 (0.07 MB
DOC)
Table S3 Top 100 genes predicted for association with
‘abnormal bone mineralization’.
Found at: doi:10.1371/journal.pcbi.1000991.s004 (0.17 MB
DOC)
Text S1 Integration of diverse data for constructing a functional
relationship network.
Found at: doi:10.1371/journal.pcbi.1000991.s005 (0.07 MB
DOC)
Text S2 Training SVMs on raw data as a baseline for
performance evaluation.
Found at: doi:10.1371/journal.pcbi.1000991.s006 (0.06 MB
DOC)
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